Video Library

Bone marrow transplant survivors have an increased risk of developing a second or “secondary” cancer later in life. This video discusses risk factors for developing a secondary cancer, cancers most frequently seen after transplant and monitoring and testing that should be done periodically to catch second cancers early when they are easiest to treat. (Throughout the talk, bone marrow transplant refers both to bone marrow transplants and stem cell transplants, as well as cord blood transplants.)

A variety of skin problems are common after a bone marrow or stem cell transplant including infections, rashes, hair loss, lesions and skin cancer. This video discusses both malignant and non-malignant skin problems, who is at risk for developing these problems, recommended skin care after transplant, and testing to prevent or diagnose skin problems early.

This presentation reviews some of the short- and long-term cardiovascular toxicities that can develop after stem cell transplantation. It describes strategies that patients and their physicians can use to reduce the risk of developing cardiovascular problems after transplant.

Several types of infection can occur after a stem cell or bone marrow transplant and can complicate recovery for patients. This presentation describes the infection risks during the posttransplant period, therapies to treat them, and some measures to prevent them.

Descargue las Diapositivas de la Presentación Infecciones después del Trasplante (Infections after Transplant) Martes 2 de mayo de 2023 Presentadora: Dra. Jennifer Cuellar-Rodriguez, MD, National Institutes of Health Transplant and

Graft-versus-host-disease (GVHD) is a common challenge for patients who undergo a stem cell transplant using cells from a donor (an allogeneic transplant). It can be mild, moderate or severe. This presentation reviews the types of GVHD, the organs most often affected, common symptoms, and traditional as well as newer therapies for treating GVHD.

Descargue las Diapositivas de la Presentación Introducción a la Enfermedad de Injerto contra Huésped (Introduction to Graft-versus-Host Disease (GVHD)) Sábado 29 de abril de 2023 Presentador: Dr. Suarez-Londono, Escuela de

Several new therapies have recently been approved to prevent and treat graft-versus-host disease (GVHD) and more are being studied. The new therapies are more effective than the standard GVHD therapies and should result in a lower incidence of GVHD with fewer toxicities for patients, going forward.

Descargue las Diapositivas de la Presentación Enfermedad de Injerto contra Huésped: Avances en la Prevención y el Tratamiento (Graft-versus-Host Disease: Advances in Prevention and Treatment) Martes 2 de mayo de

Living with graft-versus-host disease (GVHD) can be challenging not only for the patient, but for the patient’s caregiver as well. It is vital for family caregivers to maintain their own health and quality of life while caring for the patient/loved-one. This presentation presents a road map for how to do just that.

Graft-versus-host disease (GVHD) is a condition that can occur after a stem cell using donor cells (an allogenic transplant). This presentation describes how GVHD can affect the mouth, esophagus, stomach, small intestine, large intestine and liver.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant with donor cells (allogeneic transplant). This presentation discusses the manifestations of chronic GVHD on the skin, hair, and nails; how skin GVHD can affect activities of daily living; and pharmacologic and non-pharmacological therapies that can help patients who have skin GVHD